Catalyst
Slingshot members are tracking this event:
PDUFA estimate September 4, 2017 for LILETTA (levonorgestrel-releasing intrauterine system) 52 mg, for the prevention of pregnancy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AGN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 07, 2017
Occurred Source:
http://www.prnewswire.com/news-releases/fda-approves-medicines360s-snda-for-liletta-levonorgestrel-releasing-intrauterine-system-52-mg-to-prevent-pregnancy-for-up-to-four-years-300500125.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Liletta, Levonorgestrel, Pdufa Date
